Search

Showing total 359 results
Start Over Topic immune response Language english Publication Type News
359 results

1. Nature Scientific Reports has published a peer reviewed paper showing important immune response benefits associated with AOBiome's B244 Ammonia Oxidizing Bacteria drug therapy

Subjects
Bacteria, Atopic dermatitis -- Drug therapy, Immune response, Ammonia, General interest, News, opinion and commentary
Abstract

CAMBRIDGE: AOBiome has issued the following press release: AOBiome Therapeutics, Inc. ('AOBiome'), a leading clinical-stage microbiome company focusing on inflammatory conditions, announced new findings indicating a link between Ammonia Oxidizing [...]

Published
2021

2. Nature Scientific Reports has published a peer reviewed paper showing important immune response benefits associated with AOBiome's B244 Ammonia Oxidizing Bacteria drug therapy

Subjects
Bacteria, Atopic dermatitis -- Drug therapy, Immune response, Ammonia, Business, News, opinion and commentary
Abstract

B244 inhibits Th2 immune polarization in human primary immune cells in both the active and the inactive state. CAMBRIDGE, Mass., July 15, 2021 /PRNewswire/ -- AOBiome Therapeutics, Inc. ('AOBiome'), a [...]

Published
2021

3. Revolution Medicines Announces Publication of Scientific Paper Describing Anti-Tumor Immunity Induced by SHP2 Inhibitor in Preclinical Cancer Models

Subjects
Sanofi S.A., Cancer, Cellular proteins, Drugs, Cobimetinib, Pharmaceutical industry, Cancer treatment, Cancer research, Immune response, Immune system, Tumors, Business, international, Law
Abstract

(GlobeNewswire) - Revolution Medicines, Inc. (Nasdaq: RVMD), a clinical-stage oncology company focused on developing targeted therapies to inhibit frontier cancer targets, today announced the publication of an original scientific paper [...]

Published
2020

4. The Lancet publishes papers from two studies of Takeda's dengue vaccine candidate

Subjects
Takeda Pharmaceutical Company Ltd., Dengue vaccines, Vaccines, Medical research, Dengue fever, Pharmaceutical industry, Immune response, Business, Business, international
Abstract

- Results published in first paper from 18-month analysis of ongoing pivotal Phase 3 trial were generally consistent with overall efficacy and safety data reported in previously published 12-month analysis. [...]

Published
2020

5. EnGeneIC Announces Publication in Cancer Cell of a Scientific Paper Highlighting the Ability of EDV Nanocells to Mount Dual Assault on Cancer Cells

Subjects
Cancer treatment -- Health aspects, Cancer -- Health aspects, Immunotherapy -- Health aspects, Cancer cells, Technology, Immune response, Tumors, General interest, News, opinion and commentary
Abstract

NEW YORK: EnGeneIC Limited has issued the following press release: EnGeneIC Limited, a clinical-stage biopharmaceutical company advancing its proprietary EDV nanocell platform for targeted cyto-immunotherapy in cancer, today announced that [...]

Published
2020

6. AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform

Subjects
HLA antigens, Antigens, Proteins, Technology, Immune response, Biotechnology, Biotechnology industries, General interest, News, opinion and commentary
Abstract

ALAMEDA: AgeX Therapeutics, Inc. has issued the following press release: AgeX Therapeutics, Inc. ('AgeX'; NYSE American: AGE), a biotechnology company developing therapeutics for human aging and regeneration, and Juvenescence, a [...]

Published
2019

7. AgeX Therapeutics and Juvenescence Publish Paper on Engineering Strategies for Universal Cells and Provide in Vivo Observation on Immunotolerance UniverCyteTM Technology Platform

Subjects
Biomedical engineering, HLA antigens, Antigens, Technology, Immune response, Anopheles, Biotechnology, Editors, Biotechnology industries, Health
Abstract

2019 NOV 14 (NewsRx) -- By a News Reporter-Staff News Editor at Gene Therapy Weekly -- AgeX Therapeutics, Inc. ('AgeX'; NYSE American: AGE), a biotechnology company developing therapeutics for human [...]

Published
2019

10. Ebola vaccine regimen generates strong immune response in children and adults in a clinical trial in Sierra Leone

Subjects
Children -- Diseases, Ebola virus infections, Immune response, Clinical trials, Vaccines, Ebola virus, Virus diseases, Business, international, Law, University of London. London School of Hygiene and Tropical Medicine
Abstract

Johnson & Johnsons two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published [...]

Published
2021

11. SINOVAC advertises positive data for the CoronaVac(r) Booster Shots, strong adult and the elderly immune responses

Subjects
Sinovac Biotech Ltd., Biological products industry, Medical research, Medicine, Experimental, Advertising, Immune response, Adults, Vaccines, General interest, News, opinion and commentary
Abstract

BEIJING: SINOVAC Biotech Ltd., a leading provider of biopharmaceutical products in China, announced today the publication of two papers. The publications detail findings from clinical studies on the immunogenicity, safety, [...]

Published
2021

12. Mixed Oxford|Pfizer vaccine schedules generate robust immune response against COVID-19

Subjects
Pfizer Inc., AstraZeneca PLC, Vaccination, Immune response, Vaccines, Pharmaceutical industry, Business, international, Law
Abstract

Alternating doses of the Oxford-AstraZeneca and Pfizer-BioNTech vaccines generate robust immune responses against COVID-19, according to research in which UCLH played a key role. In a paper published on the [...]

Published
2021

13. Germany : How alcohol in moderation has a positive effect on impaired immune reactions

Subjects
Disease susceptibility, Immune response, Immune system, Health, Nature, Autoimmune diseases, Diseases, Business, international
Abstract

We all know that excessive consumption of alcohol is bad for our health. Moderate quantities of alcohol, however, can be beneficial to our health in some circumstances. In a paper [...]

Published
2020

14. AIVITA Biomedical Publishes Study Comparing Immune Responses and Associated Survivals Induced by Dendritic and Tumor Cell Vaccines

Subjects
Cancer vaccines, Tumors, Immunotherapy, Dendritic cells, Immune response, Vaccines, Clinical trials, Biotechnology industries, Business, international, Law
Abstract

AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today the publication of a paper titled, Cytokine network analysis of immune responses before and after autologous [...]

Published
2020

15. AIVITA Biomedical Publishes Study Comparing Immune Responses and Associated Survivals Induced by Dendritic and Tumor Cell Vaccines

Subjects
Cancer vaccines, Tumors, Immunotherapy, Dendritic cells, Immune response, Vaccines, Clinical trials, Biotechnology industries, General interest, News, opinion and commentary
Abstract

IRVINE: AIVITA Biomedical, Inc. has issued the following press release: AIVITA Biomedical, Inc., a biotechnology company specializing in innovative cell therapy applications, announced today the publication of a paper titled, [...]

Published
2020

16. aTyr Pharma Announces Publication in the Journal Cellular and Molecular Immunology

Subjects
Transfer RNA, Ligases, Immune response, RNA, Diseases, Banking, finance and accounting industries, Business
Abstract

SAN DIEGO, Feb 27, 2020 (GLOBE NEWSWIRE via COMTEX) -- Paper highlights the essential role that histidyl tRNA synthetase (HARS) plays in immune responses in a broad range of inflammatory [...]

Published
2020

17. United States : Disrupting the gut microbiome may affect some immune responses to flu vaccination

Subjects
United States. National Institute of Allergy and Infectious Diseases, Neomycin, Influenza vaccines, Metronidazole, Influenza, Vaccination, Immune response, Antibiotics, Biochemistry, Microorganisms, Allergy, Health, Scientists, Immune system, Communicable diseases, Business, international
Abstract

The normal human gut microbiome is a flourishing community of microorganisms, some of which can affect the human immune system. In a new paper published this week in Cell, researchers [...]

Published
2019

18. Peer Reviewed Scientific Publications Highlight TG4010's Ability to Induce Broad CD8+ Responses and its Synergistic Effects in Combination with Immune Checkpoint Inhibitors

Subjects
Vaccines, Chemotherapy, Immunotherapy, Immune response, Non-small cell lung cancer, General interest, News, opinion and commentary
Abstract

Cambridge, MA: Transgene has issued the following news release: Transgene (Euronext Paris: TNG), a biotech company that designs and develops viral-based immunotherapies, recently published two papers supporting the efficacy and [...]

Published
2017

19. Transgene: Peer Reviewed Scientific Publications Highlight TG4010's Ability to Induce Broad CD8+ Responses and its Synergistic Effects in Combination with Immune Checkpoint Inhibitors

Subjects
Vaccines, Immunotherapy, Immune response, Non-small cell lung cancer, General interest, News, opinion and commentary
Abstract

Amsterdam: TRANSGENE has issued the following news release: Transgene (Paris:TNG), a biotech company that designs and develops viral-based immunotherapies, recently published two papers supporting the efficacy and mechanism of action [...]

Published
2017

20. Inovio Pharmaceuticals' novel gene immunoadjuvant significantly improves DNA vaccine immune responses in non-human primates

Subjects
DNA, T cells, Genetic research, Immune response, Vaccines, Primates, Pharmaceutical industry, Business, Chemicals, plastics and rubber industries
Abstract

Inovio Pharmaceuticals Inc (Inovio) announced that the peer-reviewed journal Molecular Therapy has published a paper entitled 'IL-28B/IFN-lambda3 Drives Granzyme B Loading and Significantly Increases CTL Killing Activity in Macaques.' 'IL-28B/IFN-lambda3 [...]

Published
2010

21. Carlsbad, Calif., Biotech Company's Stock Rises after Study of AIDS Vaccine

Subjects
Immune Response, Business, Business, regional, General interest
Abstract

Apr. 24--CARLSBAD, Calif.--Investors pushed the stock of the Carlsbad biotechnology company Immune Response up by 53 percent Monday after the company announced publication of a scientific paper viewed as favorable [...]

Published
2001

22. Testing new ways of curing cancer.

Subjects
CANCER treatment, IMMUNE response
Abstract

The article focuses on several pharmaceutical companies that are committed in developing cancer drugs that can accelerate immune responses, which include Pfizer Inc., Bristol-Myers Squibb Co., and Merck & Co. Inc.

Published
2015

23. Immune response part of 1918 flu strain problem

Subjects
Influenza, Immune response, Biotechnology industry
Abstract

A paper in the Jan. 18, 2007, issue of Nature reported on the effects that the 1918 'Spanish flu' virus strain has in primates. With the 1918 virus, the host [...]

Published
2007

25. RESEARCH SPOTLIGHT: STEM-IMMUNITY HUBS ASSOCIATED WITH RESPONSE TO IMMUNOTHERAPY

Subjects
Oncology, Experimental, Immune response, Immunotherapy, Lung cancer, Cancer -- Research, News, opinion and commentary, Massachusetts General Hospital
Abstract

BOSTON, MA -- The following information was released by the Massachusetts General Hospital (MGH): Jonathan Chen, MD, PhD, an investigator in the department of Pathology at Massachusetts General Hospital and [...]

Published
2024

26. New mRNA cancer vaccine triggers fierce immune response to fight malignant brain tumor

Subjects
Cancer patients, Immune response, Gliomas, Messenger RNA, Brain tumors, Medical colleges, Vaccines, Pets, Business, Health, Health care industry, University of Florida
Abstract

2024 MAY 19 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- In a first-ever human clinical trial of four adult patients, [...]

Published
2024

27. Common immune response protective across many diseases

Subjects
Autoimmunity, Immune response, Cancer -- Care and treatment, Business, Health, Health care industry
Abstract

2024 MAR 24 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- SEATTLE - Combined, infection, autoimmunity and cancer account for four [...]

Published
2024

28. Xidian University Researchers Advance Knowledge in Mathematical Biosciences and Engineering (Longtime evolution and stationary response of a stochastic tumor-immune system with resting T cells)

Subjects
T cells, Tumors, Immune system, Biotechnology, Immune response, Biological sciences, Health
Abstract

2024 MAR 5 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- Current study results on mathematical biosciences and engineering have been published. According to news [...]

Published
2024

33. How an immune response is driven by one letter difference in DNA

Subjects
Vaccination, DNA, Genetic research, BCG vaccines, BCG, Antitubercular agents, Immune response, Tuberculosis, Vaccines, Interleukins, Health
Abstract

2023 DEC 27 (NewsRx) -- By a News Reporter-Staff News Editor at Vaccine Weekly -- One-letter difference in our DNA determines whether BCG vaccine provides good protection against tuberculosis or [...]

Published
2023

35. PDS Biotech Announces the Publication of PDS0301 Study Linking Induced Changes in Immune Responses with Clinical Outcomes in International Immunopharmacology Journal

Subjects
Medical research, Medicine, Experimental, Biotechnology, Biotechnology industry, Immune response, Immunotherapy, General interest, News, opinion and commentary
Abstract

FLORHAM PARK, N.J: PDS Biotechnology Corporation has issued the following news release: PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies for cancer [...]

Published
2023

36. New Liver Cancer Findings from Northwest University Described (Reversal of Hmga1-mediated Immunosuppression Synergizes With Immunogenic Magnetothermodynamic for Improved Hepatocellular Carcinoma Therapy)

Subjects
Cell death, Antineoplastic agents, Immune response, Immunotherapy, Cancer -- Care and treatment, Liver cancer, Antimitotic agents, Health
Abstract

2023 JUL 19 (NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Data detailed on Oncology - Liver Cancer have been presented. According to news reporting out [...]

Published
2023

37. New Findings from University of British Columbia Describe Advances in Dilated Cardiomyopathy (Role of Coxsackievirus B3-Induced Immune Responses in the Transition from Myocarditis to Dilated Cardiomyopathy and Heart Failure)

Subjects
Coxsackievirus infections, Cardiomyopathy, Dilated, Immune response, Heart, Myocarditis, Health, University of British Columbia
Abstract

2023 MAY 8 (NewsRx) -- By a News Reporter-Staff News Editor at Cardiovascular Week -- Current study results on dilated cardiomyopathy have been published. According to news reporting from Vancouver, [...]

Published
2023

38. How the body's B cell academy ensures a diverse immune response

Subjects
Viral antibodies, Immune response, B cells, Vaccines, Antibodies, Business, Health, Health care industry
Abstract

2023 FEB 5 (NewsRx) -- By a News Reporter-Staff News Editor at Medical Letter on the CDC & FDA -- Cells jostling for a spot in a germinal center face [...]

Published
2023

39. Atreca Announces Publication in PNAS: 'Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101'

Subjects
T cells, Immune response, Viral antibodies, Immunotherapy, B cells, Cancer -- Care and treatment, Antibodies, Business, international, Law, National Academy of Sciences
Abstract

(GlobeNewswire) - Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a unique discovery platform based on interrogation of the active human immune [...]

Published
2022

40. Atreca Announces Publication in PNAS: 'Mobilization of Innate and Adaptive Antitumor Immune Responses by the RNP-Targeting Antibody ATRC-101'

Subjects
T cells, Viral antibodies, Immune response, Immunotherapy, B cells, Antibodies, Banking, finance and accounting industries, Business, National Academy of Sciences
Abstract

SAN CARLOS, May 04, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START (NASDAQ:BCEL), EQNX::TICKER_END Atreca, Inc. (Atreca) (NASDAQ: BCEL), a clinical-stage biotechnology company focused on developing novel therapeutics generated through a [...]

Published
2022

42. Government College University Researchers Detail Findings in Mathematical Biosciences and Engineering (Novel stochastic dynamics of a fractal-fractional immune effector response to viral infection via latently infectious tissues)

Subjects
Biotechnology, Immune response, Biological sciences, Health
Abstract

2022 SEP 6 (NewsRx) -- By a News Reporter-Staff News Editor at Life Science Weekly -- New research on mathematical biosciences and engineering is the subject of a new report. [...]

Published
2022

43. Jabs could 'fail to protect' against new Covid variants eventually, SAGE warns; The Scientific Advisory Group for Emergencies warns jabs currently in use may 'boost protection' over the next two winters -but potentially less so for people with a 'less robust' immune response

Subjects
Immune response, General interest, News, opinion and commentary
Abstract

Byline: By, Talia Shadwell The coronavirus vaccines currently in use may eventually stop working against new variants of the virus, experts are warning. Officials will need to plan fresh solutions [...]

Published
2021

44. Covid vaccine that creates T-cells 'gives better immune response than current jabs'; CoVac-1 jab developed and made by academics at the University of Tubingen, in Germany, has strong phase one trial results

Subjects
Vaccination, T cells, Immune response, General interest, News, opinion and commentary
Abstract

Byline: Joe Pinkstone, Science Correspondent A new vaccine designed to specifically create T-cells against Covid produces a better immune response than the alternatives already in use, according to trial data. [...]

Published
2021

45. EIGHT MONTHS LATER: RESEARCHERS COMPARE IMMUNE RESPONSES ELICITED BY THREE COVID-19 VACCINES

Subjects
Pfizer Inc., Medical research, Medicine, Experimental, Medical centers, Immune response, RNA, Vaccines, Pharmaceutical industry, News, opinion and commentary, Beth Israel Deaconess Medical Center, Comirnaty (Vaccine)
Abstract

BOSTON, MA -- The following information was released by Beth Israel Deaconess Medical Center (BIDMC): Written by: Jacqueline Mitchell Contact: Chloe Meck, cmeck@bilh.org OCTOBER 15, 2021 Strong antibody response to [...]

Published
2021

46. St. Barnabas Hospital Health System Researchers Advance Knowledge in COVID-19 (Type 2 Diabetes Contributes to Altered Adaptive Immune Responses and Vascular Inflammation in Patients With SARS-CoV-2 Infection)

Subjects
Inflammation -- Care and treatment, Immune response, Health care industry, Type 2 diabetes -- Care and treatment, Acute respiratory distress syndrome -- Care and treatment, Health care industry, Health
Abstract

2022 APR 11 (NewsRx) -- By a News Reporter-Staff News Editor at Diabetes Week -- New research on coronavirus is the subject of a new report. According to news originating [...]

Published
2022

48. COVID-19 VACCINES PRODUCE IMMUNE RESPONSES IN PATIENTS WITH CHRONIC INFLAMMATORY DISEASES

Subjects
Medical research, Medicine, Experimental, Rheumatoid factor, Antiarthritic agents, Multiple sclerosis -- Care and treatment, Immune response, B cells, Arthritis -- Care and treatment, Vaccines, News, opinion and commentary, Washington University. School of Medicine
Abstract

San Francisco -- The following information was released by the University of California, San Francisco: But UCSF-Washington University Study Finds Some Treatments Inhibit Effects Much More Than Others By Suzanne [...]

Published
2021

49. Study reveals COVID-19 vaccine response in patients with impaired immune systems

Subjects
Medical research, Medicine, Experimental, Vaccination, Stem cells -- Transplantation, Immune response, Arthritis -- Care and treatment, Vaccines, Disease susceptibility -- Care and treatment, Business, international
Abstract

London: University of Oxford has issued the following news release: A national study has found that a significant proportion of clinically at-risk patients with certain immunocompromised or immunosuppressed conditions, mount [...]

Published
2021